CRPS rehabilitation with graded imagery and desensitization tailored to you
Official title: Clinical and Cerebral Changes Following Multifaceted Rehabilitation of Complex Regional Pain Syndrome: A Single-Case Experimental Design.
Run by University Hospital of North Norway · NCT02753335 · Data updated 2026-11-12
This study tests a personalized rehab program for CRPS to see if it improves daily functioning and pain, with MRI to explore brain changes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 12 (estimated) |
| Sponsor | University Hospital of North Norway Academic / other |
| Locations | 1 site (Tromsø) |
| Status | Recruiting |
| Started | September 2016 |
| Main results expected | May 2030 |
| Study ends | November 15, 2032 |
| Registry record updated | October 8, 2026 |
| Trial ID | NCT02753335 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–70 with a single- limb CRPS lasting more than 3 months who are not on high-dose opioids or with contraindicating health conditions.
✕Probably not a fit
Patients with multiple limbs affected, uncontrolled severe psychiatric illness, or contraindications to MRI may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will deliver an individualized rehabilitation program for CRPS that combines graded motor imagery and tactile desensitization within a psychologically informed care framework. The study uses a randomized multiple-baseline single-case design to track how each participant responds before and after starting treatment. Outcomes include daily CRPS interference, pain levels, and limb function, measured repeatedly, with additional assessments at baseline and 12 months. For a subset, MRI will compare brain structure with healthy controls and monitor changes over time. Two work packages jointly address clinical effects and neuroimaging under real-world clinical conditions.
Why it matters
Potential benefit: If successful, the program could reduce pain and improve daily function for people with CRPS and may reveal brain changes associated with rehabilitation.
How similar studies have gone: Previous similar approaches using graded motor imagery and desensitization have shown signals of benefit in CRPS, though evidence remains variable and this study includes innovative MRI outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older. For participants included in WP2 (MRI), the maximum age is 70 years. * Diagnosis of Complex Regional Pain Syndrome (CRPS) according to the Budapest criteria. * CRPS affecting a single upper or lower limb. * Triggering trauma or onset of pain more than 3 months before inclusion. Exclusion Criteria: * Drug abuse. * Malignant or progressive disease, systemic disease, or neurodegenerative disease. * Other severe pain conditions. * Severe anxiety or depression. * Disabling fatigue or myalgic encephalomyelitis (ME). * Use of opioid medication exceeding 100 mg oral morphine equivalents (OMEQ). Additional Exclusion Criteria for WP2 (MRI): * History of seizures. * Neurological or neurosurgical disorders. * Significant cardiac or systemic illness. * Implanted metallic or electronic devices incompatible with MRI. * Diagnosis of a developmental disorder. * Current use of antipsychotic medications, benzodiazepines, or other pharmacological agents that may influence MRI measurements. * Pregnancy or lactation. * Phobia of MRI examination.
Where it's running
-
University Hospital of North Norway
Tromsø, Norway Recruiting
Study contacts
- Study coordinator: Lena Danielsson, PhD
- Email: lena.danielsson@unn.no
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Non-invasive brain stimulation to see if it changes pain avoidance in CRPS
This study tests whether a gentle brain stimulation method called tACS can change how people with complex regional pain syndrome avoid activities that might worsen their pain.
-
tDCS for CRPS: see if a non‑invasive brain stimulation helps reduce pain
This trial tests whether transcranial direct current stimulation can lessen pain and improve mood and function for people with complex regional pain syndrome.
-
Peripersonal space changes with upper limb segmental exclusion
This study will test whether people with unilateral segmental exclusion of the upper limb perceive their reachable space differently than healthy people using a virtual-reality reachability test.
-
What happens after neridronate treatment for CRPS Type 1
This registry follows people with CRPS Type 1 to see how long the benefits of IV neridronate last over 12 to 24 months.
-
CRPS of the hand: Contrast plus compression vs whirlpool therapy
This randomized study tests whether a combined contrast therapy with intermittent compression helps people with CRPS-I in the hand and wrist more than whirlpool therapy.
-
Perineural incobotulinumtoxin-A for unilateral CRPS of an arm or leg
This study will try a single ultrasound-guided perineural injection of incobotulinumtoxin-A to see if it is safe and tolerable for adults with long-standing unilateral CRPS of an arm or leg.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.